Retrogenix Points to New Drug Target for Malaria in Children

News   Jun 06, 2013

 
Retrogenix Points to New Drug Target for Malaria in Children
 
 
 

RELATED ARTICLES

One in Five Materials Chemistry Papers May be Wrong, Study Suggests

News

The replicability of results from scientific studies has become a major source of concern in the research community, particularly in the social sciences and biomedical sciences. A new study that compared the results reported in thousands of papers published about the properties of metal organic framework (MOF) materials – which are prominent candidates for carbon dioxide adsorption and other separations – suggests the replicability problem should be a concern for materials researchers, too.

READ MORE

Children With Congenital Zika Virus Infection Face Serious Challenges as They Age

News

The report from the CDC is the first to describe the health and developmental effects of congenital Zika virus infection in children with microcephaly through 2 years of age.

READ MORE

Inflammation Causes Chemo Brain

News

The research could lead to a new practice of identifying inflammatory biomarkers in cancer patients and then treating the inflammation with medications or exercise to improve cognition and other symptoms.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE